Inadvertent Error: Evaluation of Bevacizumab for the Treatment of Epidural Fibrosis by Immunohistochemical Staining for CD105 and Osteopontin
Abstract
As the authors of the paper titled “Evaluation of
Bevacizumab for the Treatment of Epidural Fibrosis
by Immunohistochemical Staining for CD105 and
Osteopontin” published in 2018, Volume 28(6), pp. 954–962,
